Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS [PDF]
Zhongguo aizheng zazhi, 2022 Ovarian function suppression (OFS) has been used in the treatment of breast cancer for decades. Early adjuvant treatment studies have confirmed that the application of OFS alone can reduce the recurrence risk of breast cancer patients under the age of 50
Chinese Anti-Cancer Association, Committee of Breast Cancer Society
doaj +1 more source
Screening and early diagnosis of breast cancer in China: a practice guideline [PDF]
Zhongguo aizheng zazhi, 2022 Between April 2020 and November 2021, the Chinese Breast Cancer Society developed practice guideline on screening and early diagnosis of breast cancer in China, which was adapted from European Commission Initiative on Breast Cancer with GRADE approach ...
The Society of Breast Cancer, China Anti-Cancer Association
doaj +1 more source
Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version) [PDF]
Zhongguo aizheng zazhi, 2022 Recently, advances in organoid technology have opened new avenues for the development of novel models of human cancer. Patient-derived tumor organoids retain phenotypes such as histopathological, genetic and molecular features of the original tumor.
The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association
doaj +1 more source
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition) [PDF]
Zhongguo aizheng zazhi, 2022 The management of bone health in female patients with early breast cancer includes managing bone loss and preventing bone metastasis. As the overall survival of patients with early breast cancer continues to increase, bone health is getting extensive ...
The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
doaj +1 more source
Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition) [PDF]
Zhongguo aizheng zazhi, 2022 Recently, new strategies for the integrated treatment of gynecological malignancies have been improved along with the development of reproductive oncology and hereditary tumors concepts.
The Society of Gynecological Cancer of China Anti-Cancer Association
doaj +1 more source
Expert consensus on oncoplastic surgery of breast tumor and breast reconstruction (2022 edition) [PDF]
Zhongguo aizheng zazhi, 2022 With the new trend of oncoplastic surgery and breast reconstruction in China and the emergence of new evidence-based medical data, expert of Chinese Anti-Cancer Association, Committee of Breast Cancer Society convened domestic clinical experts in the ...
Committee of Breast Cancer Society, Chinese Anti-Cancer Association, Breast Surgeons Committee of Surgeons Branch, Chinese Medical Doctor Association, Committee of Breast Cancer Society, Shanghai Anti-Cancer Association
doaj +1 more source
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition) [PDF]
Zhongguo aizheng zazhi, 2023 Cancer of unknown primary (CUP) and cancer of multiple primaries (CMP) are two groups of neoplasm with high heterogeneity, low incidence, limited clinical knowledge and evidence.
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang
doaj +1 more source
Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [PDF]
Zhongguo aizheng zazhiOxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation.
Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
doaj +1 more source
The 150 most important questions in cancer research and clinical oncology series: questions 94–101
Cancer Communications, 2018 Since the beginning of 2017, Cancer Communications (former title: Chinese Journal of Cancer) has published a series of important questions regarding cancer research and clinical oncology, to provide an enhanced stimulus for cancer research, and to ...
Cancer Communications
doaj +1 more source
BMC Medicine, 2019 Cancer Research UK and Ludwig Cancer Research convened an inaugural international Cancer Prevention and Nutrition Conference in London on December 3–4, 2018.
The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group
doaj +1 more source